Armis Advisers’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
1,149
-21
-2% -$5.81K 0.02% 391
2026
Q1
$348K Sell
1,170
-74
-6% -$22K 0.03% 322
2025
Q4
$382K Buy
1,244
+348
+39% +$94.6K 0.04% 278
2025
Q3
$237K Buy
896
+28
+3% +$7.62K 0.02% 284
2025
Q2
$239K Buy
+868
New +$236K 0.02% 408

Other funds holding CME

Armis Advisers's CME Position: Q2 2026 in Review

Armis Advisers reduced its CME Group (CME) stake by 1.8% in Q2 2026, selling an estimated $5.81K and leaving 1,149 shares worth $270K. The position accounts for 0.02% of the portfolio, ranked #391.

Armis Advisers first reported a position in CME in Q2 2025 and has held it in 5 quarters since. The position peaked at $382K in Q4 2025. 297 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Armis Advisers held 1,149 shares of CME Group worth $270K as of Q2 2026.
  • Armis Advisers sold 21 CME Group shares in Q2 2026, an estimated $5.81K.
  • CME Group made up 0.02% of Armis Advisers's portfolio in Q2 2026, its #391 holding.
  • Armis Advisers first reported a position in CME Group in Q2 2025 and has held it in 5 quarters since.
  • Armis Advisers's CME Group position peaked at $382K in Q4 2025.
  • 297 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Armis Advisers's 13F filing for Q2 2026, filed 7 Jul 2026.